Ariel F Martinez1, Yu Abe2, Sungkook Hong2, Kevin Molyneux2, David Yarnell2, Heiko Löhr3, Wolfgang Driever3, Maria T Acosta2, Mauricio Arcos-Burgos4, Maximilian Muenke2. 1. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: ariel.martinez@nih.gov. 2. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland. 3. Institute of Biology I, University of Freiburg, Freiburg, Germany. 4. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland; Genome Biology Department, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Abstract
BACKGROUND: Genetic factors predispose individuals to attention-deficit/hyperactivity disorder (ADHD). Previous studies have reported linkage and association to ADHD of gene variants within ADGRL3. In this study, we functionally analyzed noncoding variants in this gene as likely pathological contributors. METHODS: In silico, in vitro, and in vivo approaches were used to identify and characterize evolutionary conserved elements within the ADGRL3 linkage region (~207 Kb). Family-based genetic analyses of 838 individuals (372 affected and 466 unaffected patients) identified ADHD-associated single nucleotide polymorphisms harbored in some of these conserved elements. Luciferase assays and zebrafish green fluorescent protein transgenesis tested conserved elements for transcriptional enhancer activity. Electromobility shift assays were used to verify transcription factor-binding disruption by ADHD risk alleles. RESULTS: An ultraconserved element was discovered (evolutionary conserved region 47) that functions as a transcriptional enhancer. A three-variant ADHD risk haplotype in evolutionary conserved region 47, formed by rs17226398, rs56038622, and rs2271338, reduced enhancer activity by 40% in neuroblastoma and astrocytoma cells (pBonferroni < .0001). This enhancer also drove green fluorescent protein expression in the zebrafish brain in a tissue-specific manner, sharing aspects of endogenous ADGRL3 expression. The rs2271338 risk allele disrupts binding of YY1 transcription factor, an important factor in the development and function of the central nervous system. Expression quantitative trait loci analysis of postmortem human brain tissues revealed an association between rs2271338 and reduced ADGRL3 expression in the thalamus. CONCLUSIONS: These results uncover the first functional evidence of common noncoding variants with potential implications for the pathology of ADHD. Published by Elsevier Inc.
BACKGROUND: Genetic factors predispose individuals to attention-deficit/hyperactivity disorder (ADHD). Previous studies have reported linkage and association to ADHD of gene variants within ADGRL3. In this study, we functionally analyzed noncoding variants in this gene as likely pathological contributors. METHODS: In silico, in vitro, and in vivo approaches were used to identify and characterize evolutionary conserved elements within the ADGRL3 linkage region (~207 Kb). Family-based genetic analyses of 838 individuals (372 affected and 466 unaffected patients) identified ADHD-associated single nucleotide polymorphisms harbored in some of these conserved elements. Luciferase assays and zebrafish green fluorescent protein transgenesis tested conserved elements for transcriptional enhancer activity. Electromobility shift assays were used to verify transcription factor-binding disruption by ADHD risk alleles. RESULTS: An ultraconserved element was discovered (evolutionary conserved region 47) that functions as a transcriptional enhancer. A three-variant ADHD risk haplotype in evolutionary conserved region 47, formed by rs17226398, rs56038622, and rs2271338, reduced enhancer activity by 40% in neuroblastoma and astrocytoma cells (pBonferroni < .0001). This enhancer also drove green fluorescent protein expression in the zebrafish brain in a tissue-specific manner, sharing aspects of endogenous ADGRL3 expression. The rs2271338 risk allele disrupts binding of YY1 transcription factor, an important factor in the development and function of the central nervous system. Expression quantitative trait loci analysis of postmortem human brain tissues revealed an association between rs2271338 and reduced ADGRL3 expression in the thalamus. CONCLUSIONS: These results uncover the first functional evidence of common noncoding variants with potential implications for the pathology of ADHD. Published by Elsevier Inc.
Authors: M Nogueira; R Bosch; S Valero; N Gómez-Barros; G Palomar; V Richarte; M Corrales; V Nasillo; R Vidal; M Casas; J A Ramos-Quiroga Journal: Compr Psychiatry Date: 2013-12-10 Impact factor: 3.735
Authors: Lu Liu; Jia Cheng; Yi Su; Ning Ji; Qian Gao; Haimei Li; Li Yang; Li Sun; Qiujin Qian; Yufeng Wang Journal: J Atten Disord Date: 2015-03-17 Impact factor: 3.256
Authors: Glaucia Chiyoko Akutagava-Martins; Angelica Salatino-Oliveira; Christian Costa Kieling; Luis Augusto Rohde; Mara Helena Hutz Journal: Expert Rev Neurother Date: 2013-04 Impact factor: 4.618
Authors: M Lange; W Norton; M Coolen; M Chaminade; S Merker; F Proft; A Schmitt; P Vernier; K-P Lesch; L Bally-Cuif Journal: Mol Psychiatry Date: 2012-04-17 Impact factor: 15.992
Authors: M Arcos-Burgos; M Jain; M T Acosta; S Shively; H Stanescu; D Wallis; S Domené; J I Vélez; J D Karkera; J Balog; K Berg; R Kleta; W A Gahl; E Roessler; R Long; J Lie; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; S Johansson; P M Knappskog; J Haavik; M Ribases; B Cormand; M Bayes; M Casas; J A Ramos-Quiroga; A Hervas; B S Maher; S V Faraone; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; A Vortmeyer; J E Bailey-Wilson; F X Castellanos; M Muenke Journal: Mol Psychiatry Date: 2010-02-16 Impact factor: 15.992
Authors: Mauricio Arcos-Burgos; F Xavier Castellanos; David Pineda; Francisco Lopera; Juan David Palacio; Luis Guillermo Palacio; Judith L Rapoport; Kate Berg; Joan E Bailey-Wilson; Maximilian Muenke Journal: Am J Hum Genet Date: 2004-10-20 Impact factor: 11.025
Authors: Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-02-08 Impact factor: 8.829
Authors: Sally H Cross; Lisa McKie; Katrine West; Emma L Coghill; Jack Favor; Shoumo Bhattacharya; Steve D M Brown; Ian J Jackson Journal: Hum Mol Genet Date: 2010-10-13 Impact factor: 6.150
Authors: Samantha L Regan; Jillian R Hufgard; Emily M Pitzer; Chiho Sugimoto; Yueh-Chiang Hu; Michael T Williams; Charles V Vorhees Journal: Neurobiol Dis Date: 2019-06-06 Impact factor: 5.996
Authors: Djenifer B Kappel; Jaqueline B Schuch; Diego L Rovaris; Bruna S da Silva; Diana Müller; Vitor Breda; Stefania P Teche; Rudimar S Riesgo; Lavínia Schüler-Faccini; Luís A Rohde; Eugenio H Grevet; Claiton H D Bau Journal: Neuromolecular Med Date: 2019-01-16 Impact factor: 3.843